Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.

deGoma EM, Ahmad ZS, O'Brien EC, Kindt I, Shrader P, Newman CB, Pokharel Y, Baum SJ, Hemphill LC, Hudgins LC, Ahmed CD, Gidding SS, Duffy D, Neal W, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Linton MF, Duell PB, Shapiro MD, Moriarty PM, Knowles JW
Circ Cardiovasc Genet. 2016 9 (3): 240-9

PMID: 27013694 · PMCID: PMC5315030 · DOI:10.1161/CIRCGENETICS.116.001381

MeSH Terms (35)

Adult Aged Biomarkers Chi-Square Distribution Cholesterol, LDL Comorbidity Coronary Disease Cross-Sectional Studies Diabetes Mellitus Down-Regulation Early Diagnosis Female Genetic Predisposition to Disease Guideline Adherence Heterozygote Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors Hyperlipoproteinemia Type II Hypertension Logistic Models Male Middle Aged Multivariate Analysis Odds Ratio Phenotype Practice Guidelines as Topic Practice Patterns, Physicians' Predictive Value of Tests Prevalence Professional Practice Gaps Registries Risk Factors Time Factors Treatment Outcome United States

Connections (1)

This publication is referenced by other Labnodes entities: